Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients - Wikidata - awgldk - TriplyDB

Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

http://www.wikidata.org/entity/Q35306297

about

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer Alzheimer's Disease associated with Psychiatric Comorbidities Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation.Unesterified docosahexaenoic acid is protective in neuroinflammation.Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging.Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder.Aging decreases rate of docosahexaenoic acid synthesis-secretion from circulating unesterified α-linolenic acid by rat liver Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging.Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjects Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4 Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients.Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.Altered lipid concentrations of liver, heart and plasma but not brain in HIV-1 transgenic rats.Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain Neuroinflammation and synaptic loss Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability.Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.Tissue-specific differences in brain phosphodiesters in late-life major depression EPA or DHA enhanced oxidative stress and aging protein expression in brain of d-galactose treated mice.Chronic treatment with anti-bipolar drugs causes intracellular alkalinization in astrocytes, altering their functions.Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia.Effects of lithium on inflammation Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture.Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.Maternal dietary n-6 polyunsaturated fatty acid deprivation does not exacerbate post-weaning reductions in arachidonic acid and its mediators in the mouse hippocampus.

P2860

Q26777966-5778EB1E-20DD-4A99-8716-BFDC8359A6E0 Q26796602-6A5B03EB-3AB3-407E-8C8D-C21647E536B0 Q26850084-71180CB1-57B9-4AD4-925C-7523980EFCC5 Q33784486-6928C866-3165-4B69-B25D-C58B1B7EF976 Q33798922-7F6B648F-BF7D-429B-8416-DF014BB19CD0 Q33806815-15199598-5450-4BEE-A14A-D55312932F09 Q33993276-47A0BC5C-7E36-438C-980B-0E73816AD258 Q34187058-31B60440-E6D0-4E56-AA72-26C4FAB75F02 Q34258505-D5CFF367-800F-4840-AC89-4B96AF3C0E3C Q34374526-1523FD2D-4E1E-4504-8EA7-A3009379ACC6 Q34566029-D16419AC-0282-490D-AA34-7F0A59562D36 Q35218379-CF9739D7-42A2-4086-84DA-D1132669E4D6 Q35224308-4F88C25F-50F9-480A-8843-762D23455A66 Q35284832-B7FACA46-0A9F-4882-93D9-A9696C648DD8 Q35308508-743DDB89-729B-4951-896B-63659386B31B Q35476477-DD78F6D0-A23A-43D3-AE7F-2D1ECFA89127 Q35662070-E7B89193-AF38-4B8A-B116-8EDF6EA0BCCA Q35742545-01461F9E-B564-4599-A56E-9EC893E86427 Q35844193-3A055777-F8A0-4C4E-9233-D3AC96A5C289 Q36010817-00538A97-B4B8-40E5-94B7-45311A89248D Q36136017-8AF5B2E5-58AE-4E99-9ED8-AE54829E54F1 Q36199755-9FC3A189-1E2E-41F8-83AB-A47ADD34E2F9 Q36217965-8CC4CCE8-6433-4BBB-8B0D-3BFD521F50EE Q36306440-77F4FE31-0DFF-4C3A-8524-DC7913855728 Q36338174-71B50C6C-55E4-4649-870B-44D5CDBAB62C Q36340687-DB1B0A38-DB7C-40D9-A83F-BB110FCFB452 Q36502629-8CFEAB15-B23A-449E-8390-8CC500BD494A Q36518167-3CF34881-20EE-4773-9CF5-7278ADCB7F38 Q36673587-9C6B3CF2-C289-409B-B30A-F75476E13CA5 Q36750552-C2829117-DF89-47C6-B475-EFA452F01075 Q37110292-8FAFBCD5-8137-4646-BE8D-3038F721B346 Q37167078-867E2B69-06C9-413D-B06B-9F649B2B5925 Q38042397-2989107F-EB1C-478C-9A4F-43C0F77691C8 Q38125218-B5EF6F0C-99FF-49BD-A146-6E562151C28C Q38150488-AEB5D4F9-7DC9-41C3-A132-1CDCB8758130 Q38209880-B75BEE81-8617-46B3-AEA7-0B15C210D447 Q38629703-8889043C-00F7-4B3E-977F-9BAD2589BC1A Q38804214-E29800D9-AB1E-4690-8672-F7CFDDBE1BAC Q39938122-28659B13-2C46-4FBA-ADBB-BC6DA4EF15A0 Q48114593-B6C522F2-1EC6-4048-ACEF-0314AC2093E3

P2860

Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

http://www.wikidata.org/entity/Q35306297

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Altered arachidonic acid casca ...... from bipolar disorder patients

@ast

Altered arachidonic acid casca ...... from bipolar disorder patients

@en

type

label

Altered arachidonic acid casca ...... from bipolar disorder patients

@ast

Altered arachidonic acid casca ...... from bipolar disorder patients

@en

prefLabel

Altered arachidonic acid casca ...... from bipolar disorder patients

@ast

Altered arachidonic acid casca ...... from bipolar disorder patients

@en

P1433

Q35306297-B76AA2AC-2F58-4B24-9F92-5D5AD4673534

P1476

Q35306297-2208BC25-3C32-4FC2-8B05-64A1D44A1C80

P2093

Q35306297-172E407A-9F42-48AA-9288-876CFE0B55CD

Q35306297-30A98797-D8A9-4244-89CA-26CA3FE8F7FB

Q35306297-BBEC1CFB-E08D-4CC4-9D46-26EA63924B4E

P2860

Q35306297-0255A257-7B7E-4E32-AE96-988395FBB064

Q35306297-03B04E24-5B88-4E09-926E-F8B5437F254E

Q35306297-06C7C2E1-5592-4B78-8263-1255811CBC30

Q35306297-087C8D20-B3A8-4EB5-B6A8-B87680B9957B

Q35306297-0A76C311-01F9-4ED5-9B37-6D64D457A6E9

Q35306297-0F2A1878-D0A4-4BBD-A486-48A9F35F86C5

Q35306297-0F697DC2-DAD1-4F11-8D18-7C6599196FDB

Q35306297-100581B9-DDB8-4241-ACE9-0F394215F123

Q35306297-17D769DD-27DB-4E86-B7C9-F0D0D6BD9952

Q35306297-1A34E1BF-F3D4-4CCF-880D-08CA9D2A237F

P2888

Q35306297-B194DF33-B57F-4745-8DC9-DE633B223F20

P304

Q35306297-F55F00CC-EAD5-4251-84F1-58BB5907FA5F

P31

Q35306297-32481F90-657F-4B45-921B-28192079F44D

P356

Q35306297-0AA7896E-FA53-4299-9C42-53ED39CC05C4

P407

Q35306297-18514963-66F7-44CC-9238-C7FB32E91198

P433

Q35306297-48EAD5D0-5164-4AFB-A806-54742B3EEBF4

P478

Q35306297-D9C86B0E-E2F7-4313-8490-738451A720E0

P577

Q35306297-E073A310-4A36-428A-B573-C45C3D7801F2

P5875

Q35306297-1063A4E0-CE27-40BD-B15C-9C666635119B

P698

Q35306297-54B17B1D-1BC9-424D-81B9-CD6322B60709

P921

Q35306297-5B91EEF8-23B2-46C9-8E5B-5488313A68CF

P932

Q35306297-D9C2581C-62A6-41E0-A5CB-12A8595914DE

P356

P1433

Molecular Psychiatry

P1476

Altered arachidonic acid casca ...... from bipolar disorder patients

@en

P2093

H-W Kim

http://www.w3.org/2001/XMLSchema#string

J S Rao

http://www.w3.org/2001/XMLSchema#string

S I Rapoport

http://www.w3.org/2001/XMLSchema#string

P2860

Affective Disorders and Suicide Risk: A Reexamination

IRAK: a kinase associated with the interleukin-1 receptor

Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein

Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys

A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology

Prostaglandins and leukotrienes: advances in eicosanoid biology

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

P2888

P304

419-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MP.2009.137

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40805891

http://www.w3.org/2001/XMLSchema#string

P698

20038946

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

3190400

http://www.w3.org/2001/XMLSchema#string